login
Become a member
Quick Registration
Full Registration Benefits -
Free Homepages for Doctors
Free Homepages for Hospitals
Free Homepages for Medical Conference
Free Homepages for NGO's
Personal Health Record Creation
Access to all Medical Slides
Access to all Jobs & Products Sale
Medindia »
Consumer Health »
Health Information »
Latest Publication and Research on Parkinsons Disease
| Disease Info Index | ||||||||||||||||||||||||||
|
|
Parkinsons Disease
Page Options
Drugs For Parkinsons Disease
amantadine
apomorphine
benztropine
biperiden
bromocriptine
cabergoline
carbidopa-levodopa
citicoline
domperidone
entacapone
levodopa
piribedil
pramipexole
procyclidine
rasagiline
ropinirole
selegiline
tolcapone
trihexyphenidyl
Parkinson's Disease
Latest Publication and Research on Parkinsons Disease
|
|
|
Text 
|
Neurosurgery Subthalamic nucleus targeting using interpeduncular cistern as an internal landmark. Deogaonkar M, Freitas T, Machado A, Rezai A *Center for Neurological Restoration, Department of Neurosurgery, Cleveland Clinic Foundation, Cleveland, Ohio ‡Department of Neurosurgery, The Ohio State University, Columbus, Ohio. Internal landmarks for the subthalamic nucleus (STN) have been used in past. This study uses a yet-unused internal landmark to refine STN targeting.... Read More Source: PubMed 2011 Dec 1 What Factors Influence Motor Complications in Parkinson Disease?: A 10-Year Prospective Study. García-Ruiz PJ, Del Val J, Fernández IM, Herranz A Departments of *Neurology and †Research & Epidemiology, Fundación Jiménez Díaz, Madrid, Spain. ABSTRACT: The causes and mechanism behind motor complications in Parkinson disease (PD) are still a subject of debate. Several factors including age a... Read More Source: PubMed 2011 Dec 3 Molecular pathogenesis of Parkinson's disease: update. Saiki S, Sato S, Hattori N Department of Neurology, Juntendo University School of Medicine, Bunkyo, Tokyo, Japan. Parkinson disease (PD) is a neurodegenerative disease characterised by progressive disturbances in motor, autonomic and psychiatric functions. Much ha... Read More Source: PubMed 2011 Dec 5 Levodopa infusion combined with entacapone or tolcapone in Parkinson disease: a pilot trial. Nyholm D, Johansson A, Lennernäs H, Askmark H Department of Neuroscience, Neurology, Uppsala University, Uppsala Department of Pharmacy, Uppsala University, Uppsala, Sweden. Background and purpose: Catechol-O-methyltransferase inhibitors may be used to decrease levodopa requirement. The objective was to investigate whethe... Read More Source: PubMed Cleve Clin J Med Essential tremor: Choosing the right management plan for your patient. Abboud H, Ahmed A, Fernandez HH Center for Neurological Restoration, U-2, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; ahmeda@ccf.org. Essential tremor is a common neurologic problem seen widely at all levels of patient care. It should be differentiated from secondary causes of tremor... Read More Source: PubMed Mayo Clin. Proc. Cheaper, simpler, and better: tips for treating seniors with Parkinson disease. Ahlskog JE Department of Neurology, Mayo Clinic, 200 First St SW, Rochester, MN 55905. eahlskog@mayo.edu. Treatment of seniors with Parkinson disease is within the domain of primary care physicians and internists. A good working knowledge of carbidopa/levo... Read More Source: PubMed 2011 Dec 6 Parkinson disease: Twin study identifies an association between exposure to a solvent and risk of Parkinson disease. Kingwell K ... Read More Source: PubMed 2011 Dec 2 Quadriceps Muscle Weakness, Activation Deficits, and Fatigue With Parkinson Disease. Stevens-Lapsley J, Kluger BM, Schenkman M BACKGROUND: . People with Parkinson disease (PD) typically have complaints of weakness. The mechanisms underlying this deficit have not been well esta... Read More Source: PubMed 2011 Dec 6 Parkinson disease: Twin study identifies an association between exposure to a solvent and risk of Parkinson disease. Kingwell K ... Read More Source: PubMed 2011 Dec 2 Quadriceps Muscle Weakness, Activation Deficits, and Fatigue With Parkinson Disease. Stevens-Lapsley J, Kluger BM, Schenkman M BACKGROUND: . People with Parkinson disease (PD) typically have complaints of weakness. The mechanisms underlying this deficit have not been well esta... Read More Source: PubMed 2011 Dec 5 Open conformation of human DOPA decarboxylase reveals the mechanism of PLP addition to Group II decarboxylases. Giardina G, Montioli R, Gianni S, Cellini B, Paiardini A, Voltattorni CB, Cutruzzolŕ F Dipartimento di Scienze Biochimiche 'A. Rossi Fanelli', Sapienza Universitŕ di Roma, Piazzale Aldo Moro 5, 00185 Rome, Italy. DOPA decarboxylase, the dimeric enzyme responsible for the synthesis of neurotransmitters dopamine and serotonin, is involved in severe neurological d... Read More Source: PubMed Exp Clin Transplant Transient improvement of acquired hepatocerebral degeneration with parkinsonian symptoms after failed liver transplant: case report and literature review. Chen Y, Haque M, Yoshida EM From the Department of Medicine, University of British Columbia, Vancouver, BC, Canada. Objectives: Acquired (non-Wilsonian) hepato-cerebral degeneration is an infrequent neurologic disorder in patients with liver dysfunction and longstan... Read More Source: PubMed Neurosurgery Subthalamic nucleus targeting using interpeduncular cistern as an internal landmark. Deogaonkar M, Freitas T, Machado A, Rezai A *Center for Neurological Restoration, Department of Neurosurgery, Cleveland Clinic Foundation, Cleveland, Ohio ‡Department of Neurosurgery, The Ohio State University, Columbus, Ohio. Internal landmarks for the subthalamic nucleus (STN) have been used in past. This study uses a yet-unused internal landmark to refine STN targeting.... Read More Source: PubMed 2011 Dec 1 What Factors Influence Motor Complications in Parkinson Disease?: A 10-Year Prospective Study. García-Ruiz PJ, Del Val J, Fernández IM, Herranz A Departments of *Neurology and †Research & Epidemiology, Fundación Jiménez Díaz, Madrid, Spain. ABSTRACT: The causes and mechanism behind motor complications in Parkinson disease (PD) are still a subject of debate. Several factors including age a... Read More Source: PubMed 2011 Dec 3 Molecular pathogenesis of Parkinson's disease: update. Saiki S, Sato S, Hattori N Department of Neurology, Juntendo University School of Medicine, Bunkyo, Tokyo, Japan. Parkinson disease (PD) is a neurodegenerative disease characterised by progressive disturbances in motor, autonomic and psychiatric functions. Much ha... Read More Source: PubMed 2011 Dec 5 Levodopa infusion combined with entacapone or tolcapone in Parkinson disease: a pilot trial. Nyholm D, Johansson A, Lennernäs H, Askmark H Department of Neuroscience, Neurology, Uppsala University, Uppsala Department of Pharmacy, Uppsala University, Uppsala, Sweden. Background and purpose: Catechol-O-methyltransferase inhibitors may be used to decrease levodopa requirement. The objective was to investigate whethe... Read More Source: PubMed Cleve Clin J Med Essential tremor: Choosing the right management plan for your patient. Abboud H, Ahmed A, Fernandez HH Center for Neurological Restoration, U-2, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; ahmeda@ccf.org. Essential tremor is a common neurologic problem seen widely at all levels of patient care. It should be differentiated from secondary causes of tremor... Read More Source: PubMed Mayo Clin. Proc. Cheaper, simpler, and better: tips for treating seniors with Parkinson disease. Ahlskog JE Department of Neurology, Mayo Clinic, 200 First St SW, Rochester, MN 55905. eahlskog@mayo.edu. Treatment of seniors with Parkinson disease is within the domain of primary care physicians and internists. A good working knowledge of carbidopa/levo... Read More Source: PubMed 2011 Dec 5 Open conformation of human DOPA decarboxylase reveals the mechanism of PLP addition to Group II decarboxylases. Giardina G, Montioli R, Gianni S, Cellini B, Paiardini A, Voltattorni CB, Cutruzzolŕ F Dipartimento di Scienze Biochimiche 'A. Rossi Fanelli', Sapienza Universitŕ di Roma, Piazzale Aldo Moro 5, 00185 Rome, Italy. DOPA decarboxylase, the dimeric enzyme responsible for the synthesis of neurotransmitters dopamine and serotonin, is involved in severe neurological d... Read More Source: PubMed Exp Clin Transplant Transient improvement of acquired hepatocerebral degeneration with parkinsonian symptoms after failed liver transplant: case report and literature review. Chen Y, Haque M, Yoshida EM From the Department of Medicine, University of British Columbia, Vancouver, BC, Canada. Objectives: Acquired (non-Wilsonian) hepato-cerebral degeneration is an infrequent neurologic disorder in patients with liver dysfunction and longstan... Read More Source: PubMed |
| Share it! |  |
 |
 |
 |
 |
 |
 |
|
|
Comment & Contribute
|
Posted by:
mohann
Posted on: 12/13/2009 i have not seen the decease known now as " Restless leg syndrome mentioned in the list. can you include this RLS and medication for this please. mohan-muscat
Reply |
Forward
Posted by:
meeta shah(Guest)
Posted on: 03/27/2009 I am sujok therapidt and giving treatmeny to parkinsion's patient.he is 72 years old.he becomes vibront in movement and feeling uncomfortable.During my treatment ,he felt relax for 10 hrs. that day.I am usuing needle accupuncture system of byol meridians and chakras and triorigine in sujok therapy.
Posted by:
alex63
Posted on: 05/09/2011 I am Acupuncture therapist myself ans have PD for 3 years. So farI have not been able to control my Tremor [ mainly on Left side of the body]. Would you be so kind and share you approach with Su Jok (I do practice it as well). Thanks a lot!
Alex |
| Related Links | ||||||||||||
|
| Citing this Health Article | ||||||
|
||||||
| News on Parkinsons Disease |
Are you a member of Facebook? Become a fan of Medindia and get breaking news delivered to your Facebook page.
